Arcellx and kite announce expansion in strategic partnership

-- arcellx to receive $200m equity investment at $61.68 per share and an $85 million upfront cash payment -- -- kite exercises option to arcellx's arc-sparx program aclx-001 in multiple myeloma -- -- the companies expand the scope of their existing collaboration for cart-ddbcma to include lymphomas -- redwood city, calif. and santa monica, calif.
ACLX Ratings Summary
ACLX Quant Ranking